Titration methods for rVSV-based vaccine manufacturing

Titration methods for rVSV-based vaccine manufacturing

The recombinant Vesicular Stomatitis Virus (rVSV) is an emerging platform for viral vector-based vaccines. Promising results have been reported in clinical trials for the rVSV-ZEBOV vaccine for Ebola virus disease prevention. In this study, we describe the titration tools elaborated to assess the ti...

Detaylı Bibliyografya
Asıl Yazarlar:	Jean-François Gélinas, Sascha Kiesslich, Rénald Gilbert, Amine A. Kamen
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2020-01-01
Seri Bilgileri:	MethodsX
Konular:	rVSV-ZEBOV Ebola rVSV-HIV HIV dPCR TCID50
Online Erişim:	http://www.sciencedirect.com/science/article/pii/S2215016120300261

Benzer Materyaller

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
Yazar:: Amanda N. Pinski, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America
Yazar:: Paola Andrea Martinez-Murillo, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
Yazar:: Anne Rechtien, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina
Yazar:: Jennifer Tisoncik-Go, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Closer than ever to an Ebola virus vaccine
Yazar:: Logan Banadyga, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)
Yazar:: Conall H. Watson, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
Yazar:: Neil Rupani, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?
Yazar:: Angela Huttner, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease
Yazar:: Joan G. Tell, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography
Yazar:: Elad Lerer, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination Efficacy
Yazar:: Sharon Melamed, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Development of Pandemic Vaccines: ERVEBO Case Study
Yazar:: Jayanthi Wolf, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP <i>Zaire ebolavirus</i> Vaccine to Inform Marburg Virus and <i>Sudan ebolavirus</i> Vaccines
Yazar:: Beth-Ann G. Coller, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein
Yazar:: Qi Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
Yazar:: Francesco Santoro, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
Yazar:: Emmie de Wit, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia
Yazar:: I. V. Dolzhikova, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV
Yazar:: Hiva Azizi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
Yazar:: Anahita Fathi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Being Pregnant during the Kivu Ebola Virus Outbreak in DR Congo: The rVSV-ZEBOV Vaccine and Its Accessibility by Mothers and Infants during Humanitarian Crises and in Conflict Areas
Yazar:: David A. Schwartz
Baskı/Yayın Bilgisi: (2020-01-01)

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques
Yazar:: Alice Berger, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
Yazar:: Guodong Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
Yazar:: Maggie Jing Ouyang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Enhanced production yields of rVSV-SARS-CoV-2 vaccine using Fibra-Cel® macrocarriers
Yazar:: Noam Cohen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Development of Long-Term Stability of Enveloped rVSV Viral Vector Expressing SARS-CoV-2 Antigen Using a DOE-Guided Approach
Yazar:: MD Faizul Hussain Khan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Selected Milestones in Antiviral Drug Development
Yazar:: Erik De Clercq
Baskı/Yayın Bilgisi: (2024-01-01)

Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review
Yazar:: Abdulaziz Molham Moglan, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
Yazar:: Till Koch, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses
Yazar:: Beatriz Perdiguero, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
Yazar:: Janine Kimpel, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

Respuesta inmune humoral de una vacuna comercial contra la estomatitis vesicular en cerdos Humoral immune response induced by a commercial vaccine against vesicular stomatitis virus (VSV) in pigs
Yazar:: John J Arboleda, ve diğerleri
Baskı/Yayın Bilgisi: (2005-08-01)

Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication
Yazar:: Richard Dambra, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection
Yazar:: Ming Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing
Yazar:: Mai Izumida, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor
Yazar:: Christopher Ton, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Improved thermal stabilization of VSV-vector with enhanced vacuum drying in pullulan and trehalose-based films
Yazar:: Jeremy A. Iwashkiw, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors
Yazar:: Hayley M. Todesco, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Repeated harvest enables efficient production of VSV-GP
Yazar:: Rebecca Habisch, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Cre-Dependent Anterograde Transsynaptic Labeling and Functional Imaging in Zebrafish Using VSV With Reduced Cytotoxicity
Yazar:: Stanislav Kler, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
Yazar:: Suman Bishnoi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)